NCT05786898

Brief Summary

The investigators currently provide the NEAR method (neuropsychological educational approach to cognitive remediation) for people with neurocognitive difficulties, without distinguishing between ASD and schizophrenia. However, the NEAR method does not address social cognition in the stimulated functions. The aim of this study is to add social scenarios to this neurocognitive method in order to improve not only neurocognitive functions, but also social cognition. Thus, NEAR would be in this adapted form a method that could be completely adapted to autism spectrum disorders in preadolescents and adults. The study will include participants aged 13-40 years, with a diagnosis of ASD. The NEAR TSA method will include 32 sessions:

  • one session (90-120 min, with one or two breaks) per week for 32 weeks (8 months), for minor participants.
  • two sessions (90 minutes each, with no breaks) per week for 16 weeks (4 months), for adult participants. The method includes 30 minutes of computerized exercises, 15 minutes of discussion on the exercises performed and the strategies applied, and the rest of the time for "bridging groups". Three evaluation are proposed:
  • an initial clinical and functional evaluation (T1), before the beginning of the program,
  • a second clinical, functional and neuropsychological evaluation (T2), within one month since the end of the program
  • a third clinical, functional and neuropsychologica evaluationl (T3), three months after the end of the program.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jan 2023Dec 2026

First Submitted

Initial submission to the registry

December 13, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

January 24, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 28, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

March 28, 2023

Status Verified

November 1, 2022

Enrollment Period

3.6 years

First QC Date

December 13, 2022

Last Update Submit

March 15, 2023

Conditions

Keywords

Autism Spectrum DisorderCognitive remediationChildrenAdults

Outcome Measures

Primary Outcomes (3)

  • Compliance

    number of sessions correctly completed/number of sessions planned

    At the end of the intervention (Month 4 for adults participants, Month 8 for minor participants)

  • Enrollment rate

    number of subjects recruited/number of subjects selected

    at the end of the inclusion period (up to 24 months after the start of the research)

  • Retention rate

    Number of subjects in post evaluation (T2)) / number of subjects recruited

    At T2 (between Mont 4 and Month 5 for adults participants ; between Month 8 and Month 9 for minor participants)

Secondary Outcomes (11)

  • Neuropsychological assessment: attentional performance

    before the start of the NEAR TSA sessions, within one month of the end of the sessions and 3 to 4 months after the end of the sessions

  • Neuropsychological assessment : processing speed

    before the start of the NEAR TSA sessions, within one month of the end of the sessions and 3 to 4 months after the end of the sessions

  • Neuropsychological assessment : flexibility (1)

    before the start of the NEAR TSA sessions, within one month of the end of the sessions and 3 to 4 months after the end of the session

  • Neuropsychological assessment : flexibility (2)

    before the start of the NEAR TSA sessions, within one month of the end of the sessions and 3 to 4 months after the end of the session

  • Neuropsychological assessment : flexibility (3)

    before the start of the NEAR TSA sessions, within one month of the end of the sessions and 3 to 4 months after the end of the session

  • +6 more secondary outcomes

Study Arms (1)

NEAR TSA

EXPERIMENTAL

Neuropsychological and Educational Approach of Cognitive Remediation, adapted for autism (NEAR-TSA)

Other: NEAR-TSA

Interventions

Neuropsychological and Educational Approach of Cognitive Remediation adapted to autism 32 sessions spread over 4 to 8 months (1 session per week for minors, 2 sessions per week for adults), lasting 90 to 120 minutes

NEAR TSA

Eligibility Criteria

Age13 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with a diagnosis Autism Spectrum Disorder (ASD) - (DSM5)
  • Attending one of the outpatient units participating in the research
  • Diagnosis confirmed by the ADI (Autism Diagnostic Interview) with at least one parent present; or by the ADOS (Autism Diagnosis Observation Schedule)
  • Score of at least 7 on the WISC5 (children) or WAIS4 (adults) comprehension subtest
  • Patient whose neuropsychological evaluation shows neurocognitive impairment as assessed by the neuropsychologist
  • Level of comprehension and communication allowing to understand the instructions of the exercises presented on the screen.
  • For children, persons who can attend a non-specialized school
  • If the patient is being treated with a psychotropic drug: stability of treatment for more than one month.

You may not qualify if:

  • Previously known diagnosis of intellectual disability
  • Misunderstanding of questions or instructions given during the diagnostic interview
  • Proven neurological pathology
  • Persons treated with electroconvulsive therapy within the last 6 months
  • Uncorrected sensory perception disorder
  • Treatment with daytime anxiolytics, and treatment with anticholinergic correctors
  • Pregnant or breastfeeding woman
  • Participants who have had cognitive remediation in the last two years
  • \- heterogeneous levels of development highlighted in the diagnostic workup including an examination of cognitive functions
  • \- out-of-school children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GHU Paris Saint-Anne

Paris, France

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Isabelle Amado

    GHU Paris Saint-Anne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2022

First Posted

March 28, 2023

Study Start

January 24, 2023

Primary Completion (Estimated)

August 24, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

March 28, 2023

Record last verified: 2022-11

Locations